Novo Nordisk’s weight loss drugs Ozempic and Wegovy are popular, and powerful. Like, really popular. So popular that they’re raising the GDP of the company’s native Denmark. So popular that food company executives are fearfully calling Novo Nordisk CEO Lars Fruergaard Jorgensen to ask for advice …